The ability of anti-AT1R to amplify angiotensin II-mediated effects was confirmed in AT1R-immunized mice that, indeed, developed skin and pulmonary inflammation, as well as dermal fibrosis [91]. The gene discussed is AGTR1; the disease is inflammatory response.